Literature DB >> 18389217

Clinical research in critically ill patients: the situation in Italy.

Nereo Zamperetti, Nicola Latronico.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18389217     DOI： 10.1007/s00134-008-1096-6

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  23 in total

1.  Waiver of consent in studies of acute brain injury.

Authors:  Guy L Clifton; Paula Knudson; Marilyn McDonald
Journal:  J Neurotrauma       Date:  2002-10       Impact factor: 5.269

2.  New regulations for the care of the critically ill patients in Italy.

Authors:  Nereo Zamperetti; Giorgio Conti
Journal:  Intensive Care Med       Date:  2004-06-15       Impact factor: 17.440

3.  The European Union Directive on Clinical Research: present status of implementation in EU member states' legislations with regard to the incompetent patient.

Authors:  F Lemaire; J Bion; J Blanco; P Damas; C Druml; K Falke; J Kesecioglu; A Larsson; J Mancebo; D Matamis; A Pesenti; J Pimentel; M Ranieri
Journal:  Intensive Care Med       Date:  2005-02-15       Impact factor: 17.440

Review 4.  Refusal of care in the ICU any meaning for doctors?

Authors:  F Lemaire; E Ferrand
Journal:  Intensive Care Med       Date:  1998-03       Impact factor: 17.440

5.  Informed consent in clinical trials in critical care: experience from the PAC-Man Study.

Authors:  Sheila E Harvey; Diana Elbourne; Joanne Ashcroft; Carys M Jones; Kathryn Rowan
Journal:  Intensive Care Med       Date:  2006-09-21       Impact factor: 17.440

6.  Early enteral immunonutrition in patients with severe sepsis: results of an interim analysis of a randomized multicentre clinical trial.

Authors:  Guido Bertolini; Gaetano Iapichino; Danilo Radrizzani; Rebecca Facchini; Bruno Simini; Paola Bruzzone; Giancarlo Zanforlin; Gianni Tognoni
Journal:  Intensive Care Med       Date:  2003-04-09       Impact factor: 17.440

7.  Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI).

Authors: 
Journal:  Lancet       Date:  1986-02-22       Impact factor: 79.321

8.  A comparison of noninvasive positive-pressure ventilation and conventional mechanical ventilation in patients with acute respiratory failure.

Authors:  M Antonelli; G Conti; M Rocco; M Bufi; R A De Blasi; G Vivino; A Gasparetto; G U Meduri
Journal:  N Engl J Med       Date:  1998-08-13       Impact factor: 91.245

9.  The effect of waiving consent on enrollment in a sepsis trial.

Authors:  Djillali Annane; Hervé Outin; Caroline Fisch; Eric Bellissant
Journal:  Intensive Care Med       Date:  2004-01-09       Impact factor: 17.440

10.  Perceptions of cancer patients and their physicians involved in phase I trials.

Authors:  C Daugherty; M J Ratain; E Grochowski; C Stocking; E Kodish; R Mick; M Siegler
Journal:  J Clin Oncol       Date:  1995-05       Impact factor: 44.544
View more
  9 in total

1.  Surgical Intensive Care Unit Optimal Mobilisation Score (SOMS) trial: a protocol for an international, multicentre, randomised controlled trial focused on goal-directed early mobilisation of surgical ICU patients.

Authors:  Matthew J Meyer; Anne B Stanislaus; Jarone Lee; Karen Waak; Cheryl Ryan; Richa Saxena; Stephanie Ball; Ulrich Schmidt; Trudy Poon; Simone Piva; Matthias Walz; Daniel S Talmor; Manfred Blobner; Nicola Latronico; Matthias Eikermann
Journal:  BMJ Open       Date:  2013-08-19       Impact factor: 2.692

2.  The accuracy of transcranial Doppler in excluding intracranial hypertension following acute brain injury: a multicenter prospective pilot study.

Authors:  Frank A Rasulo; Rita Bertuetti; Chiara Robba; Francesco Lusenti; Alfredo Cantoni; Marta Bernini; Alan Girardini; Stefano Calza; Simone Piva; Nazzareno Fagoni; Nicola Latronico
Journal:  Crit Care       Date:  2017-02-27       Impact factor: 9.097

3.  Comparison between a nurse-led weaning protocol and weaning based on physician's clinical judgment in tracheostomized critically ill patients: a pilot randomized controlled clinical trial.

Authors:  Nazzareno Fagoni; Simone Piva; Elena Peli; Fabio Turla; Elisabetta Pecci; Livio Gualdoni; Bertilla Fiorese; Frank Rasulo; Nicola Latronico
Journal:  Ann Intensive Care       Date:  2018-01-22       Impact factor: 6.925

Review 4.  Year in review in Intensive Care Medicine, 2008: III. Paediatrics, ethics, outcome research and critical care organization, sedation, pharmacology and miscellanea.

Authors:  Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; François Lemaire; Herwig Gerlach; Johan Groeneveld; Goran Hedenstierna; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Philipp Metnitz; Jerôme Pugin; Jan Wernerman; Haibo Zhang
Journal:  Intensive Care Med       Date:  2009-02-10       Impact factor: 17.440

5.  Small nerve fiber pathology in critical illness.

Authors:  Nicola Latronico; Massimiliano Filosto; Nazzareno Fagoni; Laura Gheza; Bruno Guarneri; Alice Todeschini; Raffaella Lombardi; Alessandro Padovani; Giuseppe Lauria
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

6.  Validation of the peroneal nerve test to diagnose critical illness polyneuropathy and myopathy in the intensive care unit: the multicentre Italian CRIMYNE-2 diagnostic accuracy study.

Authors:  Nicola Latronico; Giovanni Nattino; Bruno Guarneri; Nazzareno Fagoni; Aldo Amantini; Guido Bertolini
Journal:  F1000Res       Date:  2014-06-11

Review 7.  Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy.

Authors:  Paola Toniati; Simone Piva; Marco Cattalini; Emirena Garrafa; Francesca Regola; Francesco Castelli; Franco Franceschini; Paolo Airò; Chiara Bazzani; Eva-Andrea Beindorf; Marialma Berlendis; Michela Bezzi; Nicola Bossini; Maurizio Castellano; Sergio Cattaneo; Ilaria Cavazzana; Giovanni-Battista Contessi; Massimo Crippa; Andrea Delbarba; Elena De Peri; Angela Faletti; Matteo Filippini; Matteo Filippini; Micol Frassi; Mario Gaggiotti; Roberto Gorla; Michael Lanspa; Silvia Lorenzotti; Rosa Marino; Roberto Maroldi; Marco Metra; Alberto Matteelli; Denise Modina; Giovanni Moioli; Giovanni Montani; Maria-Lorenza Muiesan; Silvia Odolini; Elena Peli; Silvia Pesenti; Maria-Chiara Pezzoli; Ilenia Pirola; Alessandro Pozzi; Alessandro Proto; Francesco-Antonio Rasulo; Giulia Renisi; Chiara Ricci; Damiano Rizzoni; Giuseppe Romanelli; Mara Rossi; Massimo Salvetti; Francesco Scolari; Liana Signorini; Marco Taglietti; Gabriele Tomasoni; Lina-Rachele Tomasoni; Fabio Turla; Alberto Valsecchi; Davide Zani; Francesco Zuccalà; Fiammetta Zunica; Emanuele Focà; Laura Andreoli; Nicola Latronico
Journal:  Autoimmun Rev       Date:  2020-05-03       Impact factor: 9.754

8.  Impact of a posttraumatic cerebral infarction on outcome in patients with TBI: the Italian multicenter cohort INCEPT study.

Authors:  Nicola Latronico; Simone Piva; Nazzareno Fagoni; Lorenzo Pinelli; Michele Frigerio; Davide Tintori; Maurizio Berardino; Andrea Bottazzi; Livio Carnevale; Tiziana Casalicchio; Carlo Alberto Castioni; Simona Cavallo; Davide Cerasti; Giuseppe Citerio; Marco Fontanella; Serena Galiberti; Alan Girardini; Paolo Gritti; Ornella Manara; Paolo Maremmani; Roberta Mazzani; Giuseppe Natalini; Mirko Patassini; Maria Elena Perna; Ilaria Pesaresi; Danila Katia Radolovich; Maurizio Saini; Roberto Stefini; Cosetta Minelli; Roberto Gasparotti; Francesco A Rasulo
Journal:  Crit Care       Date:  2020-02-03       Impact factor: 9.097

9.  The Association Between Peri-Hemorrhagic Metabolites and Cerebral Hemodynamics in Comatose Patients With Spontaneous Intracerebral Hemorrhage: An International Multicenter Pilot Study Analysis.

Authors:  Frank Rasulo; Simone Piva; Soojin Park; Mauro Oddo; Murad Megjhani; Danilo Cardim; Ilaria Matteotti; Leonardo Gandolfi; Chiara Robba; Fabio Silvio Taccone; Nicola Latronico
Journal:  Front Neurol       Date:  2020-10-26       Impact factor: 4.003
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.